| Course | NU680 Gynecological, Reproductive, and Sexual Health |
|---|---|
| Unit | Unit 5 |
| Paper type | Seminar reflection |
| Length | About 860 words, 6 pages double-spaced |
| Format | APA 7 student paper |
| School | Purdue University Global |
| Program | MSN |
| Updated | October 2026 |
Free sample paper for NU680 Unit 5
Vaccinate Every Forty-Year-Old Who Asks? A Unit 5 Seminar Reflection on a Recommendation Built for Conversation
[Student Name]
Purdue University Global
NU680: Gynecological, Reproductive, and Sexual Health
Unit 5 Seminar Reflection
[Instructor Name]
[Date]
The seminar, classmates and patient are composite; classmates are described by role; the sources cited are real.
The Question and My Starting Position
The instructor set the seminar around the 2019 change from the Advisory Committee on Immunization Practices. Routine HPV vaccination is recommended through age 26, but for adults aged 27 through 45 the committee recommends shared clinical decision making rather than a routine recommendation (Meites et al., 2019). The seminar question was whether that wording should mean "vaccinate on request" in a women's health practice.
I started on the yes side. The vaccine is safe, it prevents cancers, and I could not see the harm in giving it to anyone who wanted it. Turning a patient away, or talking her out of a cancer prevention measure, felt wrong.
What Changed My Mind
Two contributions moved me.
A classmate who works in an infectious disease clinic explained why the committee chose different wording for older adults. The vaccine prevents new infections with the HPV types it covers; it does not treat infections a person already has. By the late twenties most sexually active adults have already been exposed to at least some of those types, so the expected benefit per dose falls with age and number of past partners (Markowitz & Schiller, 2021). The committee's own modeling found vaccination in this age group much less cost-effective than in adolescents. That was not an argument against vaccinating anyone; it was an argument that the decision depends on the person.
The instructor then asked what "shared clinical decision making" actually requires. My answer, that the patient asks and I agree, was not enough. The phrase means the clinician and patient weigh the likely benefit for her specifically, given her history and future risk, and decide together. A patient who has had one partner for twenty years and is now starting to date again may gain more than a patient in a long monogamous relationship who has had many partners before it. Neither answer is automatic.
Shared decision making is not a polite name for agreeing; it is a conversation the guideline expects to happen.
The Patient I Kept Thinking About
During the discussion I kept picturing a patient I will call Ms. Petrakis, a composite 41-year-old high school chemistry teacher. She was married for twenty years, monogamous throughout, and divorced last spring. She has never been vaccinated against HPV, her cervical screening has always been normal, and she has begun dating. She read that the vaccine is now approved through age 45 and asked whether she should get it.
Under my starting position I would simply have ordered it. Under the position I left with, I would ask a few more questions and explain the reasoning. Her history suggests limited past exposure and likely new exposure ahead, which is close to the profile in which vaccination is most likely to help an adult in this age range. So the conversation would probably end in vaccination, but for reasons she understands. I would also tell her plainly that vaccination does not replace cervical screening, that her screening schedule does not change, and that the three-dose series for adults means two more visits over six months. Insurance coverage for adults in this age group is usually available under the shared decision recommendation, but she should confirm it.
Changes to My Practice
To begin, I would stop treating the recommendation as either a yes or a no. For adults over 26 I would ask about relationship status, expected new partners and past vaccination, then share my estimate of benefit in plain terms.
Second, I would document the conversation. Shared decision making is a clinical process, and the chart should show that the patient's history and preferences were weighed, whatever the decision.
Third, I would separate vaccination from screening every time I mention either. Several classmates admitted that patients sometimes believe the vaccine means they can skip screening, and the reverse is also common.
What Remains Unsettled
One question from the seminar stayed with me. A classmate asked whether the same reasoning should apply to a patient who has just been treated for cervical precancer. A 2022 meta-analysis found that vaccination around the time of an excision was linked to fewer recurrences of high-grade disease, though the authors judged the certainty of that evidence low and called for trials (Kechagias et al., 2022). U.S. guidance has not settled, so I would read the newest trials before forming a view. The question shows how a recommendation written for prevention meets patients whose histories do not fit it neatly.
Conclusion
I came into the seminar thinking the kindest answer was always yes. I left understanding that the guidance for older adults asks for something more respectful: an honest estimate of benefit for the person in front of me and a decision made together. For many patients, like Ms. Petrakis, that conversation will still end with a vaccine, but she will know why.
References
Kechagias, K. S., Kalliala, I., Bowden, S. J., Athanasiou, A., Paraskevaidi, M., Paraskevaidis, E., Dillner, J., Nieminen, P., Strander, B., Sasieni, P., Veroniki, A. A., & Kyrgiou, M. (2022). Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: Systematic review and meta-analysis. BMJ, 378, e070135. https://doi.org/10.1136/bmj-2022-070135
Markowitz, L. E., & Schiller, J. T. (2021). Human papillomavirus vaccines. The Journal of Infectious Diseases, 224(Suppl. 4), S367-S378. https://doi.org/10.1093/infdis/jiaa621
Meites, E., Szilagyi, P. G., Chesson, H. W., Unger, E. R., Romero, J. R., & Markowitz, L. E. (2019). Human papillomavirus vaccination for adults: Updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morbidity and Mortality Weekly Report, 68(32), 698-702. https://doi.org/10.15585/mmwr.mm6832a3
NU680 Unit 5 instructions, in plain terms
Unit 5 in NU680 usually centers on a live seminar that debates a screening, vaccination or prevention recommendation, followed by a written reflection. The prompt typically asks where you started, which arguments you heard, what moved and how your practice would change as a result. A written alternative is offered to students who miss the session, with its own length and requirements. The reflection should be personal in voice, but the clinical content must rest on the actual recommendation, so citing it correctly matters. Instructors look for a specific change in reasoning connected to something said in the seminar, applied to a patient. About two pages is common, sometimes a little more, with short headings or a clear sequence. One to three sources in APA format, usually the guideline at the center of the debate and a review of the evidence behind it, fit most sections.
Inside the NU680 Unit 5 example
This reflection states the seminar question and the starting position in its first section, so the change that follows is easy to see. Two contributions are then described by role: an infectious disease nurse explaining why benefit falls with age and prior exposure, citing Markowitz and Schiller, and the instructor asking what shared decision making requires. A highlighted line names the shift. The composite patient section applies the new view to Ms. Petrakis, whose history suggests limited past exposure and likely new exposure ahead, and covers screening, the three-dose series and coverage. A practice section lists three changes: asking about history before deciding, documenting the conversation and separating vaccination from screening. The open question about vaccinating after treatment for cervical precancer cites Kechagias and colleagues' meta-analysis, including its low certainty rating. The conclusion restates the shift in two sentences.
Reading the NU680 Unit 5 grading rubric
For the HPV debate, NU680 graders weigh five things: evidence that you took part, how deeply you reflect, how you apply the insight, whether the recommendation is stated correctly and the writing. Engagement means the reflection shows what was actually said, with contributions attributed by role. Depth rewards a reflection that admits a change in thinking and explains what caused it, rather than one that repeats an unchanged opinion. Application is often weighted most heavily and asks how the insight would change care for a specific patient. Accuracy matters because a reflection can misstate a recommendation; the age range, the meaning of shared decision making and the dose schedule should be correct. Identifying a question the seminar left unresolved, and saying how you would pursue it, earns credit in many sections. Organized paragraphs, a professional tone and correctly cited sources complete the rubric for this unit in most NU680 sections.
NU680 Unit 5 help from the desk
The weakest NU680 reflections retell the hour topic by topic and never say which point moved the writer. Another common weakness is a reflection centered on presenting nerves or group dynamics rather than the clinical question. Some students state a recommendation inaccurately, for example describing adult HPV vaccination as routine through 45 or as not recommended at all. Others apply the topic to practice in general terms without a patient. Forgetting to cite the guideline under discussion costs easy points. Before writing, note the one moment in the seminar that made you reconsider, then picture a patient for whom that moment would change your advice. If you missed the session, check whether the written alternative asks for the same elements. Send your seminar notes and the reflection prompt, and a reflection can be drafted around what you heard.
Get an NU680 Unit 5 example written to your instructions
Share what the seminar covered, the question you were asked and the reflection prompt with its rubric. A custom reflection connects the debate to a patient decision and shows how your thinking changed. It is free the first time and arrives within 24-48h. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
More NU680 papers and MSN samples
- NU680 Unit 1: Sexual History Discussion Post
- NU680 Unit 2: Amenorrhea Workup Paper
- NU680 Unit 3: Contraceptive Counseling Plan
- NU680 Unit 4: Infertility Evaluation Brief
- NU680 Unit 6: Genitourinary Syndrome Case Analysis
- NU680 Unit 7: Diagnostic Reasoning Paper
- NU680 Unit 8: Treatment Decision Paper
- NU680 Unit 9: Policy Brief
- NU680 Unit 10: Inclusive Care Plan
- MN501 Unit 5: Seminar Reflection
- NU678 Unit 5: Practice Issue, Child Psychiatry Access
- MN502 Unit 5: Seminar Reflection
- NU677 Unit 5: Advance Directive Reflection
NU680 Unit 5 questions, answered
What if I missed the NU680 Unit 5 seminar?
Most sections offer a written alternative assignment, usually responding to the seminar material. Check its instructions, since its length and required elements may differ from the reflection. The same standard applies: apply the topic to practice.
Should the reflection cite sources?
Usually one or two, especially when you describe a recommendation. The reflection is personal, but the clinical content should rest on current guidance. Cite the recommendation you discuss so the reader can check it.
How long is a seminar reflection?
Many prompts ask for about two pages. Focus on one or two points from the seminar and what they mean for your practice rather than summarizing the whole session.
Where can I find a free NU680 Unit 5 sample paper?
This page has the complete NU680 Unit 5 seminar reflection. It records a debate over HPV vaccination for adults aged 27 to 45, explains what shared clinical decision making requires and applies it to a composite 41-year-old patient.
Does the NU680 Unit 5 reflection say adults over 26 should not be vaccinated?
No. It explains that vaccination for adults aged 27 through 45 is decided case by case, because expected benefit depends on past and future exposure. For the composite patient in the sample, the conversation ends with vaccination.